CompletedPhase 2NCT01450137

Tocilizumab for Patients With Giant Cell Arteritis

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Insel Gruppe AG, University Hospital Bern
Principal Investigator
Peter M Villiger, Prof
Department of Rheumatology, Clinical Immunology Allergology, University Hospital, Inselspital
Intervention
Tocilizumab + Glucocorticoids (GCs)(drug)
Enrollment
30 enrolled
Eligibility
50 years · All sexes
Timeline
20112015

Study locations (1)

Collaborators

University of Bern · Roche Pharma AG

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01450137 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials